Tilray Brands TLRY
NASDAQ TLRY
$4.60 -0.23 (-4.76%)
At close: Aug 20, 2026 · 1:55 PM UTC

Tilray Brands (TLRY) Non-Current Deferred Tax Liability (2018 - 2026)

Tilray Brands' (TLRY) quarterly Non-Current Deferred Tax Liability came in at $40.3 million in Q2 2026, down 12.57% YoY from $46.1 million in Q2 2025, and up 411.54% on a QoQ basis from $7.9 million in Q1 2026.

Tilray Brands (TLRY) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 9 years of Non-Current Deferred Tax Liability data on file, last reported at $40.3 million in Q2 2026.

  • Quarterly Non-Current Deferred Tax Liability fell 12.57% year-over-year to $40.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $40.3 million (down 12.57% YoY) and the FY2026 annual result came in at $40.3 million, down 12.57% from the prior year.
  • Non-Current Deferred Tax Liability advanced to $40.3 million in Q2 2026, from $7.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $244.5 million in Q2 2024 to a low of $1.9 million in Q3 2025.
  • A 5-year average of $131.7 million and a median of $164.4 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 46.09% — and 2025, when it sank 98.57%.
  • Tracing TLRY's Non-Current Deferred Tax Liability over 5 years: stood at $180.1 million in 2022, then decreased by 7.58% to $166.5 million in 2023, then slipped by 24.32% to $126.0 million in 2024, then sank by 95.54% to $5.6 million in 2025, then surged by 616.72% to $40.3 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $40.3 million (Q2 2026), $7.9 million (Q1 2026), and $5.6 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.91 Bn 42.95 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn -
10 Tilray Brands 513.87 Mn 279.24 Mn 90.52 Mn

Historic Data

Download Data
DateValue
May 31, 2026 40.29 Mn
May 31, 2026 40.29 Mn
Feb 28, 2026 7.88 Mn
Feb 28, 2026 7.88 Mn
Nov 30, 2025 5.62 Mn
Nov 30, 2025 5.62 Mn
Aug 31, 2025 1.94 Mn
Aug 31, 2025 1.94 Mn
May 31, 2025 46.09 Mn
May 31, 2025 46.09 Mn
Nov 30, 2024 125.98 Mn
Nov 30, 2024 125.98 Mn
Aug 31, 2024 136.23 Mn
Aug 31, 2024 136.23 Mn
May 31, 2024 244.50 Mn
May 31, 2024 244.50 Mn
Feb 29, 2024 161.04 Mn
Feb 29, 2024 161.04 Mn
Nov 30, 2023 166.45 Mn
Nov 30, 2023 166.45 Mn